RecruitingNCT06073418

Dietary Habits, Nutritional Knowledge and Physical Activity Assessment in Early Stage Breast Cancer Patients

Dietary Habits, Nutritional Knowledge and Physical Activity Assessment in Early Stage Breast Cancer Patients (DEMETRA)

Sponsor

Centro di Riferimento Oncologico - Aviano

Enrollment

1,098 participants

Start Date

Oct 28, 2022

Study Type

OBSERVATIONAL

Conditions

Breast Cancer

Summary

The advances in early detection coupled with improvements in treatments have led to an ever increasing number of breast cancer survivors. New methods to improve outcomes, including strategies aimed at improving the quality of life and reducing the risk of other diseases, may complement the currently available treatment options. In particular, interventions targeting diet, weight and physical activity can reduce the risk of cancer occurrence, prevent cancer recurrence, and improve survival and the quality of life.This cross-sectional, prospective, observational study aims at evaluating dietary habits and nutritional knowledge in patients with early hormone receptor positive and hormone receptor negative breast cancer.

Eligibility

Sex: FEMALEMin Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study surveys the diet, nutrition knowledge, and physical activity habits of women who have been treated for early-stage breast cancer. The goal is to understand how lifestyle factors may affect recovery and long-term health in breast cancer survivors. **You may be eligible if...** - You are a woman aged 18 or older - You have had early-stage breast cancer (stage I–IIIa) surgically removed - Your breast cancer is either hormone receptor-positive (and you may be on hormonal therapy) or hormone receptor-negative (and you are in follow-up after treatment) - You have given written consent to participate **You may NOT be eligible if...** - You have advanced or metastatic breast cancer - You are currently receiving chemotherapy or targeted neoadjuvant/adjuvant therapy - You are unable to complete questionnaires Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Locations(1)

IRCCS, Centro di Riferimento Oncologico (CRO) di Aviano

Aviano, Pordonone, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06073418

Related Trials

Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer

NCT034128771 location

A Randomized Two-Arm Proof of Concept Study Testing A Novel Approach to Exercise Promotion Based on Affect-regulation

NCT062589931 location

ABemacicliB or Abemaciclib and HydroxYchloroquine to Target Minimal Residual Disease in Breast Cancer

NCT045238571 location

Repeat Breast Conserving Surgery Followed by Daily Partial Breast Irradiation in Ipsilateral Breast

NCT061297472 locations

Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer

NCT06982521158 locations